Eighth UPS Pain in the Chain Survey Snapshot
Among this year's key findings was the news that healthcare and life sciences logistics decision makers saw success addressing product security. Their reported success rate in this area saw a 20 percent jump over 2014 findings.
Also, the survey found that healthcare companies made further headway in regulatory compliance. This is particularly welcome, because the industry can expect only more scrutiny, regulations, and compliance burdens moving forward.
Product damage and spoilage remains a concern as products become more complex and in-transit monitoring and intervention options are underused. Companies saw success through partnerships with higher-quality shipping companies and the use of faster shipping service levels, with 63 percent reporting success in addressing product damage and spoilage issues. However, opportunities for further improvement remain.
Cost management is still a substantial supply chain issue, even though the level of concern is declining year-over-year.
Contingency planning is an area that healthcare and life sciences companies may find hard to justify investments in, based on the limited and unpredictable effect of disruptions to the supply chain. Unplanned events have impacted healthcare supply chains in the last 3-5 years, but a large percentage of supply chain decision makers still do not consider the subject important.